![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 41, 29075-29080, October 8, 1999
From the Department of Biochemistry and Molecular Biology, the
Indiana University Cancer Center and Walther Oncology Center, Indiana
University School of Medicine, Indianapolis, Indiana 46202
Eukaryotic replication protein A (RPA) is a
single-stranded DNA-binding protein with multiple functions in DNA
replication, repair, and genetic recombination. RPA contains an
evolutionarily conserved 4-cysteine-type zinc finger motif
(X3CX2-4CX12-15CX2C) that has a potential role in regulation of DNA replication and repair
(Dong, J., Park, J-S., and Lee, S-H. (1999) Biochem. J. 337, 311-317 and Lin, Y.-L., Shivji, M. K. K., Chen, C.,
Kolodner, R., Wood, R. D., and Dutta, A. (1998) J. Biol. Chem. 273, 1453-1461), even though the zinc finger itself
is not essential for its DNA binding activity (Kim, D. K.,
Stigger, E., and Lee, S.-H. (1996) J. Biol. Chem. 271, 15124-15129). Here, we show that RPA single-stranded DNA (ssDNA)
binding activity is regulated by reduction-oxidation (redox) through
its zinc finger domain. RPA-ssDNA interaction was stimulated 10-fold by
the reducing agent, dithiothreitol (DTT), whereas treatment of RPA with
oxidizing agent, diazene dicarboxylic acid
bis[N,N-dimethylamide] (diamide), significantly reduced
this interaction. The effect of diamide was reversed by the addition of
excess DTT, suggesting that RPA ssDNA binding activity is regulated by
redox. Redox regulation of RPA-ssDNA interaction was more effective in
the presence of 0.2 M NaCl or higher. Cellular redox
factor, thioredoxin, was able to replace DTT in stimulation of RPA DNA binding activity, suggesting that redox protein may be involved in RPA
modulation in vivo. In contrast to wild-type RPA, zinc finger mutant (cysteine to alanine mutation at amino acid 486) did not
require DTT for its ssDNA binding activity and is not affected by
redox. Together, these results suggest a novel function for a putative
zinc finger in the regulation of RPA DNA binding activity through
cellular redox.
The replication protein A
(RPA1; also known as human
single-stranded DNA-binding protein) is a three-subunit complex (70-, 34-, and 11-kDa; p70, p34, and p11, respectively) essential for DNA
replication, nucleotide excision repair, and genetic recombination (54). In simian virus 40 (SV40) replication, RPA mediates unwinding of
replication origin in the presence of SV40 T-antigen and topoisomerase I/II. During replication, it interacts with SV40 T-antigen and DNA
polymerase In nucleotide excision repair, RPA interacts with several key repair
proteins, Xeroderma pigmentosum (XP) group A-complementing protein, XPA (12-15), XPG (13), and XPF-excision repair
cross-complementation group 1 (16). RPA stabilizes the XPA-damaged DNA
complex through the interaction with XPA, which appears to be essential
for DNA repair (14, 17). RPA itself can interact with UV-damaged DNA (18); however, the physiological relevance of RPA-damaged DNA interaction in DNA repair is not clear. RPA is also involved in the
later stage of nucleotide excision repair, gap-filling reaction, in
collaboration with proliferating cell nuclear antigen, replication factor-C, and pol The large subunit of RPA, p70, has multiple functional domains,
including pol In mammalian cells, DNA damage or heat shock induces inhibition of
replication that can be efficiently reversed by the addition of human
RPA (33, 34), suggesting a role for RPA in regulation of DNA
replication in response to environmental stress. It is not clear how
RPA is involved in stress-induced replication arrest; however, an
observation with severe combined immunodeficient mice cells (35) argues
that RPA phosphorylation by ionizing radiation correlates with its
reduced ssDNA binding activity, suggesting a possible role of RPA
phosphorylation in stress-induced replication arrest. In contrast, an
in vitro experiment with hyperphosphorylated form of RPA
demonstrated that DNA replication and repair activities were not
affected by RPA p34 phosphorylation (36).
In this study, we found that RPA ssDNA binding activity is regulated
through its zinc finger domain via reduction-oxidation (redox), one of
the major regulatory mechanisms in response to environmental stress. A
possible role for zinc finger domain in redox regulation is discussed below.
Proteins and Chemicals--
Thioredoxin,
N-ethylmaleimide (NEM), and diamide (diazene dicarboxylic
acid bis[N,N-dimethylamide]) were obtained from Sigma, and
DTT was purchased from Roche Molecular Biochemicals.
Preparation of Wild-type and Mutant RPA--
RPA was prepared
according to the procedure described previously (37) with slight
modifications. Briefly, lysates were prepared from insect cells (Sf-9)
coinfected with recombinant baculoviruses encoding wild-type p11,
wild-type p34, and either wild-type or mutant p70. After adjusting the
salt concentration to 0.5 M NaCl, lysates were loaded onto
a ssDNA cellulose column equilibrated with buffer A (25 mM
Tris-HCl, pH 7.5, 10% glycerol, 0.02% Nonidet P-40, 1 mM
DTT, 0.5 mM EDTA, 0.1 mM phenylmethylsulfonyl
fluoride, 0.1 µg/ml leupeptin, and 0.2 µg/ml antipain) containing
0.5 M NaCl. The column was successively washed with 20 column volumes of the buffer A containing 0.5 M NaCl and
0.8 M NaCl. The proteins were eluted with buffer A
containing 2.0 M NaCl, 40% ethylene glycol. The eluted
fractions were diluted 5-fold with buffer A and loaded onto an Affi-Gel
Blue (Bio-Rad) column that was equilibrated with buffer A containing
0.5 M NaCl. After washing the column with buffer A
containing 0.5 M NaCl and 0.8 M NaCl, proteins
were eluted with buffer containing 2.5 M NaCl, 40%
ethylene glycol. The RPA-containing fractions were pooled and dialyzed
against buffer A containing 50 mM NaCl and further purified
on a Q-Sepharose column with a linear salt gradient (50 mM
to 0.4 M NaCl). All purification procedures were carried
out at 4 °C, and during purification, RPA was monitored by
immunoblotting using anti-p70 and -p34 antibodies (37). The fractions
with at least 90% purity by Coomassie staining were collected and
stored at RPA-ssDNA Binding Assay--
Oligo(dT)50 was
5'-end-labeled with [ RPA ssDNA Binding Activity Is Regulated by Redox--
In an effort
to understand the regulatory function of RPA, we examined whether RPA
ssDNA binding activity is affected by redox. For this, RPA was
preincubated with various amounts of DTT and examined for its
interaction with oligo(dT)50 in the presence of 200 mM NaCl. RPA-DNA complex was analyzed by electrophoretic mobility shift assay on polyacrylamide gel under equilibrium conditions (Fig. 1a and data not shown).
A very low RPA-DNA complex was formed in the absence of DTT, which was
stimulated up to 10-fold by the addition of DTT (Fig. 1a).
To examine redox regulation further, RPA was treated with the oxidizing
agent diamide in the presence of 0.4 mM DTT. The addition
of increasing amounts of diamide gradually decreased the formation of
RPA-DNA complex (Fig. 1b). The inhibitory effect of diamide
(3.2 mM) on RPA-DNA interaction was reversed by DTT only
when added more than the stoichiometric amounts (Fig. 1c;
lanes 7-8). These results strongly suggest that RPA ssDNA binding activity is regulated by redox potential.
Effect of Reducing Agents on RPA-ssDNA Interaction--
We then
examined how redox potential affects RPA DNA binding affinity. In the
absence of DTT, RPA ssDNA binding activity was sensitive to NaCl,
whereas under reducing conditions (1 mM DTT), RPA formed a
stable complex with ssDNA even in the presence of 1.0 M
NaCl (Fig. 2a). This result
suggests that redox affects RPA ssDNA binding affinity such that
RPA-ssDNA interaction was significantly enhanced under reducing
conditions. Thioredoxin and redox factor-1 (ref-1; also known as
apurinic/apyrimidinic endonuclease) have previously been shown to
mediate redox regulation of nuclear proteins such as transcription
factor, activator protein-1, and glucocorticoid receptor (38, 39). As
part of an effort to identify a cellular factor(s) involved in redox
regulation of RPA, we also examined whether RPA DNA binding activity
can be modulated by thioredoxin, a ubiquitous redox enzyme involved in
the formation of reversible disulfide bonds (40). Incubation of RPA
with thioredoxin stimulated RPA-ssDNA complex under conditions where
RPA itself or with the buffer (without thioredoxin) showed no DNA
binding activity (Fig. 2b), suggesting that RPA DNA binding activity may be regulated by a redox protein in vivo.
RPA DNA Binding Activity Is Inhibited by a Sulfhydryl Group
Modifying Agent, NEM--
Cellular redox plays a key role in
modulating DNA binding activity of several transcription factors, such
as Fos-Jun (41), CCAAT-binding factor (also known as NF-Y) (42), p53
(43), and Pax 8 (44). Mutational analysis of these proteins indicated that cysteine residues are involved in redox regulation (38, 42, 44).
RPA ssDNA binding activity was sensitive to diamide (Fig.
1b), a chemical that catalyzes the oxidation of free
sulfhydryl groups (45), suggesting a possible involvement of cysteine
residues in the redox-dependent DNA binding activity of
RPA. We therefore examined whether RPA ssDNA binding activity is
sensitive to NEM, which alkylates the free sulfhydryl group (Fig.
3). NEM treatment completely abolished
RPA ssDNA binding activity (Fig. 3, lanes 5-7), whereas RPA
DNA binding activity was not affected by NEM when added after DTT,
suggesting that the effect of NEM on RPA DNA binding activity is due to
the alkylation of sulfhydryl group (Fig. 3, lanes 8-10).
The inhibitory effect of NEM on RPA ssDNA binding activity strongly
indicates that cysteine residues are involved in the redox regulation
of RPA DNA binding activity.
Involvement of Zinc Finger Cysteine(s) in Redox Regulation of
RPA--
RPA p70 contains an evolutionarily conserved 4-cysteine-type
zinc finger domain at amino acids 478-503 (28). Even though previous
studies showed that the zinc finger domain is not essential for DNA
binding activity of RPA (3-5), it is possible that RPA DNA binding
domain is subjected to regulation by the zinc finger. We therefore
examined whether the cysteine residues of the zinc finger domain are
involved in redox regulation of its ssDNA binding activity. In contrast
to wild-type RPA, zinc finger mutant-4 (ZFM-4; Cys to Ala mutation at
amino acids 481, 486, 500, and 503) formed a stable complex with ssDNA
even under nonreducing conditions, and the addition of DTT had no
effect on its DNA binding activity (Fig.
4a). Two other zinc finger
mutants, ZFM-1 (Cys to Ala at amino acid 486) and ZFM-2 (Cys to Ala
mutation at 481 and 486), also formed a very stable complex with ssDNA
in the absence of DTT, which was not affected by DTT (Fig.
4b). To further examine redox regulation of zinc finger
domain, wild-type RPA and ZFM-4 were treated with the oxidizing agent,
H2O2, in the presence of 0.4 mM DTT
(Fig. 4c). The addition of increasing amounts of
H2O2 significantly reduced the RPA-DNA complex,
whereas zinc finger mutant (ZFM-4) (1) was much less affected by
H2O2 treatment (Fig. 4c). These
results strongly suggest that the zinc finger is involved in the redox
regulation of RPA ssDNA binding activity and that the cysteine residues
of p70, in particular cysteine 486, are essential for this
regulation.
Zn(II) Is Necessary for Redox Regulation of ssDNA Binding
Activity--
If RPA is a Zn(II) metalloprotein and Zn(II) is bound to
the 4-cysteine complex, the presence of Zn(II) would be able to protect these cysteines from oxidation. To test this, we examined whether a
strong divalent cation chelator, o-phenanthroline, affects
RPA ssDNA binding activity in response to redox change. The addition of
o-phenanthroline abolished the stimulatory effect of DTT on RPA ssDNA binding activity (Fig.
5a), suggesting a positive
role for Zn(II) in redox regulation of RPA. In contrast,
p-phenanthroline, a nonchelating agent, had no effect on the
stimulation of RPA ssDNA binding activity (data not shown). To
investigate this further, we compared wt-RPA and zinc finger mutant
(ZFM4; Cys to Ala mutations at 481, 486, 500, and 503) for their ssDNA
binding activity in the presence of o-phenanthroline. The
ssDNA binding activity of wt-RPA was sensitive to
o-phenanthroline in the presence of DTT, whereas ZFM4 was
not affected at all by this chelating agent (Fig. 5b).
Furthermore, the inhibitory effect of o-phenanthroline on RPA ssDNA binding was reversed by the addition of Zn(II), indicating that the inhibitory effect of o-phenanthroline on RPA ssDNA
binding is due to chelation of Zn(II) (Fig. 5c). Together,
these results strongly suggest that Zn(II) is involved in supporting
the model for the role of zinc finger domain in redox regulation (Fig.
6b).
Zinc fingers are not only autonomously folding structural elements
but also are the DNA binding component for many sequence-specific DNA
binding proteins and nuclear hormone receptors (46). A number of zinc
finger proteins have been identified in which their DNA binding
activity is regulated by redox, although the role of the zinc finger in
this regulation is not clear (47-49). In this study, we found that RPA
ssDNA binding activity is regulated by redox through the cysteines in a
putative zinc finger domain.
The 4-cysteine type zinc finger is evolutionarily conserved among
eukaryotic RPA and contains highly conserved hydrophobic and charged
amino acids that may be important for the formation of zinc finger
structure (Fig. 6a). The 4-cysteine zinc finger contains
Zn(II), which tetrahedrally coordinates four cysteine residues (50).
Under reducing conditions, the zinc finger structure is favorably
formed, and Zn(II), buried in the interior, stabilizes the module by
binding 4 cysteines (Fig. 6b). This zinc finger structure
protects cysteine 486 (and other cysteine residues) from being engaged
in the formation of disulfide bond(s). Under nonreducing (or oxidized)
conditions, however, oxidation of Zn(II)-thiolate bond induces the
releases of Zn(II) from the zinc finger (51), which promotes the
formation of disulfide bonds between the cysteine 486 and other
cysteine (Fig. 6b). It is reasonable to assume that one
disulfide bond is formed between cysteine 486 and the other cysteine,
because the Cys to Ala mutation at amino acid 486 was sufficient enough
to make it redox-insensitive (Fig. 6b). In fact, our study
on the reactivity of cysteine residues to 5,5'-dithiobis(2-nitrobenzoic acid) indicated that two zinc finger-derived cysteines are lost on
oxidation (data not shown), supporting a model that a single disulfide
bond is formed in the zinc finger domain. Disulfide bonds may be formed
between cysteine 486 and the other cysteine in the zinc finger region,
which induces a structural change that interferes with the DNA binding
domain of p70 (Fig. 6b). Alternatively, a disulfide bond may
be formed between cysteine 486 and the other cysteine outside of the
zinc finger, which leads to the alteration of protein conformation that
affects RPA DNA binding activity. To understand the role of zinc finger
further, a direct measurement of the actual release of Zn(II) from RPA
upon oxidation by atomic absorption or by spectrophotometric
measurement using 4-(2-pyridylazo)resorcinol needs to be done once we
have enough RPA.
In T4 bacteriophage, removal of the intrinsic Zn(II) ion in its
single-stranded DNA-binding protein (T4 gene 32) resulted in facile
oxidation of the cysteine, which significantly decreased ssDNA binding
activity (52). In T4 gene 32, models for the oxidized and metal-free
protein are essentially inactive while reduced, and fully metal-bound
forms are active in ssDNA binding (52, 53). However, the substitutional
mutation of metal binding cysteine to serine in T4 gene 32 was
essentially inactive in ssDNA binding (52), whereas a zinc finger
mutation of human RPA (single-stranded DNA-binding protein) made it
redox-insensitive without affecting its ssDNA binding activity (Fig.
4). These results suggest that Zn(II) binding cysteine(s) of T4 gene 32 is an essential element for its ssDNA binding, but that of human RPA
functions as a regulatory element.
Redox regulation of RPA likely occurs in vivo because RPA is
involved in replication arrest in response to environmental stress (33,
34).2 Even though the
formation of disulfide bond is favorable under oxidized conditions, it
is still possible that cysteine 486 exists another oxidized form
in vivo. For example, involvement of the glutathione/glutathione disulfide redox pair, an important cellular defense against oxidative stress (55), is considered a possibility. Another example of oxidative signaling is S-nitrosylation of
cysteine residues in p21ras oncogene by nitric oxide (56), even
though it is unclear whether this is a reversible
intercellular-signaling scheme.
Zinc finger proteins are one of the largest classes of DNA-binding
proteins and are the major targets for redox regulation since they all
contain cysteine residues as part of the metal binding finger
structure, which are essential for DNA binding activity (46). Cysteine
residues have been identified in several non-zinc finger transcription
factors as involved in redox regulation of their DNA binding activity
(42, 57). However, it is not clear whether the zinc finger itself is
directly involved in redox regulation simply because the zinc finger is
an essential DNA binding component and any mutation at a cysteine
residue (of zinc finger) will irreversibly inactivate DNA binding
activity. Unlike these zinc finger proteins, the RPA zinc finger is not
a DNA binding component and has a little or no effect on its DNA
binding activity (1, 3-5), which makes it an excellent model to study
the role of redox in regulation of zinc finger protein. We conclude
from this study that the RPA zinc finger has a role in regulating its DNA binding activity through redox change, which may be involved in
regulation of DNA metabolism in response to various environmental stress.
We thank Drs. M. Kelley and D. Giedroc for
the suggestions during the course of experiments, Dr. D. Ohannesian for
critical reading of the manuscript, and E-J. Oh for the art work.
*
This research was supported by National Institutes of Health
Grants GM52358, Council for Tobacco Research United States of America
Grant 4317, and a grant from the Indiana University Cancer Center.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
2
J-S. Park, M. Wang, and S-H. Lee, unpublished data.
The abbreviations used are:
RPA, replication
protein A;
DTT, dithiothreitol;
diamide, diazene dicarboxylic acid
bis[N,N-dimethylamide];
NEM, N-ethylmaleimide;
ZFM, zinc finger mutant;
pol
Zinc Finger of Replication Protein A, a Non-DNA Binding Element,
Regulates Its DNA Binding Activity through Redox*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-primase (pol
-primase) complex (6, 7), which is
necessary for the initiation of SV40 DNA replication (7-9). RPA is
also involved in the elongation phase of DNA replication, because it
stimulates pol
, pol
, and pol
activity on a primed template
DNA (10, 11).
(or pol
) (19). In homologous recombination, RPA physically interacts with Rad51 and Rad52, which appears to be
essential for initiation of recombination (20-24).
stimulation, ssDNA binding, and a conserved zinc
finger domain with 4-cysteine type (3, 5, 25). The ssDNA binding domain
of RPA resides in the middle of p70 (3-5), and the structural analysis
revealed that this domain consists of two homologous subdomains in
tandem position (26). The DNA binding domain but not the polymerase
stimulation domain is essential for the function of RPA in replication
(27). Both yeast RPA and human RPA share a highly conserved putative
metal binding domain of the 4-cysteine type
(X3CX2-4CX12-15CX2C) toward the C terminus (amino acids 478-503) (28, 29) of p70. Zinc
finger domain in several DNA-binding proteins such as SP1 transcription
factors and adenovirus DNA-binding protein plays a key role in the
interaction with DNA (30-32). Deletion analysis indicated that the
zinc finger domain of RPA, unlike others, is not essential for its
ssDNA binding activity (2, 4, 27). However, mutation at the zinc finger
domain differentially affected its function in replication and
nucleotide excision repair (1, 2), suggesting a possible role for zinc
finger domain in regulation.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
80 °C until use.
-32P]ATP (ICN) and T4
polynucleotide kinase (Amersham Pharmacia Biotech) based on the manufacturer's instructions. The indicated amount of wild-type or
mutant RPA was incubated with 100 fmol of 5'-32P-labeled
oligo(dT)50 at room temperature for 15 min in the reaction mixtures (30 µl) containing 50 mM Hepes-KOH (pH 7.8), 10 mM MgCl2, poly(dI·dC) (0.2 µg), bovine
serum albumin (0.2 µg/µl), and indicated amounts of DTT or NaCl.
Protein-DNA complexes were analyzed using 5% polyacrylamide gels in
1 × Tris borate EDTA (acrylamide:bisacrylamide = 79:1). The
gels were dried and exposed to x-ray films (Eastman Kodak Co). The
bands of interest were excised from the gels and measured for
radioactivity using a Beckman Scintillation Counter LS 6500.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (63K):
[in a new window]
Fig. 1.
RPA DNA binding activity is stimulated by a
reducing agent, DTT (panel a), but is inhibited by the
oxidizing agent, diamide (panel b). a,
Wild-type recombinant human RPA (20 ng) was preincubated with 0 mM (lane 2), 0.02 mM (lane
3), 0.2 mM (lane 4), 2 mM
(lane 5), and 20 mM DTT (lane 6), and
then 100 fmol of 5'-32P-labeled oligo(dT)50 was
added and allowed to incubate for 15 min at room temperature. No RPA
was included in lane 1. The RPA-DNA complex was analyzed by
5% polyacrylamide gel electrophoresis (acrylamide:bisacrylamide = 79:1). For quantitation, regions of RPA-DNA complex shown in the figure
were excised and measured for radioactivity. b, RPA (20 ng)
was preincubated with 0.4 mM DTT and increasing amounts of
diamide (0, 0.4, 1.0, 2.0, 4.0, and 10 mM diamide in
lanes 2-7, respectively). Lane 1 contained no
RPA. The RPA-DNA complex was analyzed by the procedure described in
panel a. The inhibitory effect of diamide on RPA ssDNA
binding activity is reversed by the addition of excess DTT (panel
c). c, RPA (20 ng) was preincubated with 3.2 mM diamide and increasing amounts of DTT (0, 0.4, 1.0, 2.0, 4.0, and 8.0 mM DTT in lanes 3-8,
respectively). Lane 1 contained no RPA, and lane
2 contained 0.4 mM DTT but no diamide.

View larger version (65K):
[in a new window]
Fig. 2.
Effect of reducing agents on RPA ssDNA
binding activity. a, titration of NaCl on RPA ssDNA
binding activity in the presence and absence of DTT. Wild-type RPA (20 ng) was treated with 0 mM (lanes 2-8) or 1 mM DTT (lanes 9-15) for 15 min at room
temperature before incubation for 15 min with 100 fmol of
5'-32P-labeled oligo(dT)50 in the presence of 0 mM (lanes 2 and 9), 25 mM
(lanes 3 and 10), 50 mM (lanes
4 and 11), 100 mM (lanes 5 and
12), 200 mM (lanes 6 and
13), 500 mM (lanes 7 and
14), or 1000 mM (lanes 8 and
15) of NaCl. After the reactions, the RPA-DNA complex was
analyzed by the procedure described in Fig. 1a.
b, effect of redox protein, thioredoxin, on RPA DNA binding
activity. Wild-type RPA (20 ng) was incubated with an increasing amount
(2 and 4 µl) of DTT-containing buffer (20 mM Hepes-KOH,
pH 7.8, 50 µM DTT, 60 mM KCl, 0.1 mM EDTA, and 5% glycerol) (lanes 3 and
4, respectively) or the same buffer containing 75 ng
(lane 5) or 150 ng (lanes 6 and 7) of
thioredoxin. Lane 8 contained 2 mM DTT instead
of thioredoxin. After 15 min at room temperature, 100 fmol of
5'-32P-labeled oligo(dT)50 was added to the
reactions mixtures and subsequently analyzed for RPA-DNA complex as
described in Fig. 1a.

View larger version (97K):
[in a new window]
Fig. 3.
Inhibition of RPA DNA binding activity by a
sulfhydryl group modifying agent,
N-ethylmaleimide. Where indicated, 10 ng
(lanes 2, 5, and 8), 20 ng
(lanes 3, 6, and 9), or 40 ng
(lanes 4, 7, and 10) of RPA was used.
Various amounts of RPA were treated with either 2 mM DTT
(lanes 2-4), 5 mM NEM (lanes 5-7),
or 50 mM DTT followed by 5 mM NEM (lanes
8-10) before incubation with 100 fmol of
5'-32P-labeled oligo(dT)50. The RPA-DNA complex
was analyzed by gel mobility shift assay as described in Fig.
1a.

View larger version (40K):
[in a new window]
Fig. 4.
Cysteine residue(s) of zinc finger is
involved in redox regulation of RPA DNA binding activity.
a, comparison between wild-type (W.T.) RPA and
zinc finger mutant (ZFM-4) for ssDNA binding activity in the presence
of varying concentrations of DTT. Twenty ng of either wild-type RPA
(lanes 2-6) or ZFM-4 (lanes 7-11) were
pretreated with 0 mM (lanes 2 and 7),
0.02 mM (lanes 3 and 8), 0.2 mM (lanes 4 and 9), 2 mM
(lanes 5 and 10), and 20 mM
(lanes 6 and 11) DTT and further incubated for 15 min at room temperature after the addition of 100 fmol of
5'-32P-labeled oligo(dT)50. The RPA-DNA complex
was analyzed as described in Fig. 1a. b, effect
of DTT on ssDNA binding activity of the zinc finger mutant. Twenty ng
of ZFM-1 (lanes 2-4) or ZFM-2 (lanes 5-7) was
pretreated with 0 mM (lanes 2 and 5),
0.2 mM (lanes 3 and 6), and 2 mM (lanes 4 and 7) of DTT and, after
the addition of 100 fmol of 5'-32P-labeled
oligo(dT)50, their DNA binding activity was analyzed.
c, twenty ng of either wild-type RPA (lanes 2-7)
or ZFM-4 (lanes 8-11) were pretreated with 0 mM
(lanes 2 and 8), 0.2 mM (lane
3), 0.5 mM (lanes 4 and 9), 1 mM (lanes 5 and 10), 2 mM
(lanes 6 and 11), and 5 mM
(lane 7) H2O2 in the presence of 0.4 mM DTT. Lane 1 contained no RPA. After 15 min at
room temperature, 100 fmol of 5'-32P-labeled
oligo(dT)50 was added to the reaction mixtures, and the
RPA-DNA complex was analyzed by the procedure described in Fig.
1a.

View larger version (58K):
[in a new window]
Fig. 5.
Effect of Zn(II) chelating agent,
o-phenanthroline, on RPA ssDNA binding activity.
a, increasing amounts of wt-RPA (5, 10, 15, and 20 ng,
respectively) (lanes 2-13) were pretreated with 0 mM DTT (lanes 2-5), 1.0 mM DTT
(lanes 6-9), or 1.0 mM of DTT and
o-phenanthroline (lanes 10-13) and further
incubated for 15 min at room temperature after the addition of 100 fmol
of 5'-32P-labeled oligo(dT)50. No RPA was
included in lane 1. The RPA-DNA complex was analyzed by 5%
polyacrylamide gel electrophoresis (acrylamide:bisacrylamide = 79:1). b, Zn(II)-chelating agent,
o-phenanthroline, inhibited wt-RPA ssDNA binding activity
but not that of zinc finger mutant (ZFM4). Twenty ng of either wt-RPA
(lanes 2-3) or ZFM4 (lanes 4-5) were pretreated
with 1 mM DTT (lanes 2-5) or 1.0 mM
o-phenanthroline (lanes 3 and 5). No
RPA was included in lane 1. c, reversal of
inhibitory effect of o-phenanthroline on RPA ssDNA binding
activity by Zn(II). Twenty ng of wt-RPA (lanes 2-4) was
pretreated with 1.0 mM DTT (lanes 2-4), 1.0 mM o-phenanthroline (lanes 3-4), or
1.0 mM of Zn(II) (lane 4) and further incubated
for 15 min. After the addition of 100 fmol of
5'-32P-labeled oligo(dT)50, RPA-DNA complex was
analyzed by 5% polyacrylamide gel electrophoresis. No RPA was included
in lane 1.

View larger version (28K):
[in a new window]
Fig. 6.
A proposed model for redox-mediated change in
zinc finger structure and regulation of RPA DNA binding
activity. a, zinc finger domain
(X3CX2-4CX12-15CX2C)
of eukaryotic RPA. Conserved amino acids are indicated in
bold-type (cysteines), boxed (hydrophobic
residues), and underlines (charged residues). b,
a stable zinc finger structure is formed under reducing condition.
Under oxidizing condition, Zn(II) is released from the zinc finger
structure, which induces the formation of disulfide bond(s) between
cysteine residues, including 486. The open bar indicates the
RPA DNA binding domain. Xenopus l, Xenopus
laevis; S. pombe, Schizosaccharomyces pombe;
S. cerevisiae, Saccharoymces cerevisiae; C. elegans, Caenorhabditis elegans; C. fasciculata, Crithidia fasciculata.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Biochemistry
and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202. Tel.: 317-278-3464; Fax: 317-274-4686; E-mail:
slee@iupui.edu.
![]()
ABBREVIATIONS
-primase, polymerase
-primase;
XP, Xeroderma pigmentosum;
ssDNA, single-stranded DNA;
wt, wild
type.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Dong, J.,
Park, J-S.,
and Lee, S-H.
(1999)
Biochem. J.
337,
311-317
2.
Lin, Y.-L.,
Shivji, M. K. K.,
Chen, C.,
Kolodner, R.,
Wood, R. D.,
and Dutta, A.
(1998)
J. Biol. Chem.
273,
1453-1461 3.
Kim, D.-K.,
Stigger, E.,
and Lee, S.-H.
(1996)
J. Biol. Chem.
271,
15124-15129 4.
Gomes, X. V.,
Henricksen, L. A.,
and Wold, M. S.
(1996)
Biochemistry
35,
5586-5595[CrossRef][Medline]
[Order article via Infotrieve]
5.
Lin, Y.-L.,
Chen, C.,
Keshav, K. F.,
Winchester, E.,
and Dutta, A.
(1996)
J. Biol. Chem.
271,
17190 6.
Dornreiter, I.,
Erdile, L. F.,
Gilbert, I. U.,
von Winkler, D.,
Kelly, T. J.,
and Fanning, E.
(1992)
EMBO J.
11,
769-776[Medline]
[Order article via Infotrieve]
7.
Lee, S.-H.,
and Kim, D.-K.
(1995)
J. Biol. Chem.
270,
12801-12807 8.
Collins, K. L.,
and Kelly, T. J.
(1991)
Mol. Cell. Biol.
11,
2108-2115 9.
Melendy, T.,
and Stillman, B.
(1993)
J. Biol. Chem.
268,
3389-3395 10.
Kenny, M. K.,
Lee, S.-H.,
and Hurwitz, J.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
9757-9761 11.
Lee, S.-H.,
Pan, Z.-Q.,
Kwong, A. D.,
Burgers, P. M. J.,
and Hurwitz, J.
(1991)
J. Biol. Chem.
266,
22707-22717 12.
Matsuda, T.,
Saijo, M.,
Kuraoka, I.,
Kobayashi, T.,
Nakatsu, Y.,
Nagai, A.,
Enjoji, T.,
Masutani, C.,
Sugasawa, K.,
Hanaoka, F.,
Yasui, A.,
and Tanaka, K.
(1995)
J. Biol. Chem.
270,
4152-4157 13.
He, Z.,
Henricksen, L. A.,
Wold, M. S.,
and Ingles, C. J.
(1995)
Nature
374,
566-569[CrossRef][Medline]
[Order article via Infotrieve]
14.
Li, L.,
Lu, X.,
Peterson, C. A.,
and Legerski, R. J.
(1995)
Mol. Cell. Biol.
15,
5396-5402[Abstract]
15.
Lee, S.-H.,
Kim, D.-K.,
and Drissi, R.
(1995)
J. Biol. Chem.
270,
21800-21806 16.
Matsunaga, T.,
Park, C.-H.,
Bessho, T.,
Mu, D.,
and Sancar, A.
(1996)
J. Biol. Chem.
271,
11047-11050 17.
Stigger, E.,
Drissi, R.,
and Lee, S.-H.
(1998)
J. Biol. Chem.
273,
9337-9343 18.
Burns, J. L.,
Guzder, S. N.,
Sung, P.,
Prakash, S.,
and Prakash, L.
(1996)
J. Biol. Chem.
271,
11607-11610 19.
Aboussekhra, A.,
Biggerstaff, M.,
Shivji, M. K.,
Vilpo, J. A.,
Moncollin, V.,
Podust, V. N.,
Protic, M.,
Hubscher, U.,
Egly, J. M.,
and Wood, R. D.
(1995)
Cell
80,
859-868[CrossRef][Medline]
[Order article via Infotrieve]
20.
Park, M. S.,
Ludwig, D. L.,
Stigger, E.,
and Lee, S.-H.
(1996)
J. Biol. Chem.
271,
18996-19000 21.
New, J. H.,
Sugiyama, T.,
Zaitseva, E.,
and Kowalczykowski, S. C.
(1998)
Nature
391,
407-410[CrossRef][Medline]
[Order article via Infotrieve]
22.
Hays, S. L.,
Firmenich, A. A.,
Massey, P.,
Banerjee, R.,
and Berg, P.
(1998)
Mol. Cell. Biol.
18,
4400-4406 23.
Sugiyama, T.,
New, J. H.,
and Kowalczykowski, S. C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
6049-6054 24.
Shen, Z.,
Cloud, K. G.,
Chen, D. J.,
and Park, M. S.
(1996)
J. Biol. Chem.
271,
148-152 25.
Gomes, X. V.,
and Wold, M. S.
(1995)
J. Biol. Chem.
270,
4534-4543 26.
Bochkarev, A.,
Pfuetzner, R. A.,
Edwards, A. M.,
and Frappier, L.
(1997)
Nature
385,
176-181[CrossRef][Medline]
[Order article via Infotrieve]
27.
Kim, D.-K.,
Stigger, E.,
and Lee, S.-H.
(1996)
J. Biol. Chem.
271,
15124-15129
28.
Erdile, L. F.,
Heyer, W.-D.,
Kolodner, R.,
and Kelly, T. J.
(1991)
J. Biol. Chem.
266,
12090-12098 29.
Ishiai, M.,
Sanchez, J. P.,
Amin, A. A.,
Murakami, Y.,
and Hurwitz, J.
(1996)
J. Biol. Chem.
271,
20868-20878 30.
Pan, T.,
and Coleman, J. E.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2077-2081 31.
Eagle, P. A.,
and Klessig, D. F.
(1992)
Virology
187,
777-782[CrossRef][Medline]
[Order article via Infotrieve]
32.
Narayan, V. A.,
Kriwacki, R. W.,
and Carradona, J. P.
(1996)
J. Biol. Chem.
272,
7801-7809 33.
Carty, M. P.,
Zernik-Kobak, M.,
McGrath, S.,
and Dixon, K.
(1994)
EMBO J.
13,
2114-2123[Medline]
[Order article via Infotrieve]
34.
Wang, Y.,
Perrault, A. R.,
and Iliakis, G.
(1998)
Radiat. Res.
149,
284-293[Medline]
[Order article via Infotrieve]
35.
Fried, L. M.,
Koumenis, C.,
Peterson, S. R.,
Green, S. L.,
van Zijl, P.,
Allalunis-Turner, J.,
Chen, D. J.,
Fishel, R.,
Giaccia, A. J.,
Brown, J. M.,
and Kirchgessner, C. U.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13825-13830 36.
Pan, Z. Q.,
Park, C. H.,
Amin, A. A.,
Hurwitz, J.,
and Sancar, A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4636-4640 37.
Stigger, E.,
Dean, F. B.,
Hurwitz, J.,
and Lee, S.-H.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
579-583 38.
Xanthoudakis, S.,
and Curran, T.
(1992)
EMBO J.
11,
653-665[Medline]
[Order article via Infotrieve]
39.
Grippo, J. F.,
Holmgren, A.,
and Pratt, W. B.
(1985)
J. Biol. Chem.
260,
93-97 40.
Holmgren, A.
(1985)
Annu. Rev. Biochem.
54,
237-271[CrossRef][Medline]
[Order article via Infotrieve]
41.
Abate, C.,
Patel, L.,
Rauscher III, F. J.,
and Curran, T.
(1990)
Science
249,
1157-1161 42.
Nakshatri, H.,
Bhat-Nakshatri, P.,
and Currie, R. A.
(1996)
J. Biol. Chem.
271,
28784-28791 43.
Jayaraman, L.,
Murthy, K. G. K.,
Zhu, C.,
Curran, T.,
Xanthoudakis, S.,
and Curran, T.
(1997)
Genes Dev.
11,
558-570 44.
Tell, G.,
Scaloni, A.,
Pellizzari, L.,
Formisano, S.,
Pucillo, C.,
and Damante, G.
(1998)
J. Biol. Chem.
273,
25062-25072 45.
Kosower, N. S.,
and Kosower, E. M.
(1987)
Methods Enzymol.
143,
264-270[Medline]
[Order article via Infotrieve]
46.
Clarke, N. D.,
and Berg, J. M.
(1998)
Science
282,
2018-2022 47.
Hutchison, K. A.,
Matic, G.,
Meshinchi, S.,
Bresnick, E. H.,
and Pratt, W. B.
(1991)
J. Biol. Chem.
266,
10505-10509 48.
Gowen, L. C.,
Avrutskaya, A. V.,
Latour, A. M.,
Koller, B. H.,
and Leadon, S. A.
(1998)
Science
281,
1009-1012 49.
Wu, X.,
Bishopric, N. H.,
Discher, D. J.,
Murphy, B. J.,
and Webster, K. A.
(1996)
Mol. Cell. Biol.
16,
1035-1046[Abstract]
50.
Luisi, B. F.,
Xu, W. X.,
Otwinowski, Z.,
Freedman, L. P.,
Yamamoto, K. R.,
and Sigler, P. B.
(1991)
Nature
352,
497-505[CrossRef][Medline]
[Order article via Infotrieve]
51.
Casadevall, M.,
and Sarkar, B.
(1998)
J. Inorg. Biochem.
71,
147-152[CrossRef][Medline]
[Order article via Infotrieve]
52.
Giedroc, D. P.,
Qiu, H.,
Khan, R.,
King, G. C.,
and Chen, K.
(1992)
Biochemistry
31,
765-774[CrossRef][Medline]
[Order article via Infotrieve]
53.
Qiu, H.,
Kodadek, T.,
and Giedroc, D. P.
(1994)
J. Biol. Chem.
269,
2773-2781 54.
Wold, M.
(1997)
Annu. Rev. Biochem.
66,
61-92[CrossRef][Medline]
[Order article via Infotrieve]
55.
Thomas, J. A.,
Poland, B.,
and Honzatko, R.
(1995)
Arch. Biochem. Biophys.
319,
1-9[CrossRef][Medline]
[Order article via Infotrieve]
56.
Lander, H. M.,
Milbank, A. J.,
Tauras, J. M.,
Hajjar, D. P.,
Hempastead, B. L.,
Schwartz, G. D.,
Kraemer, R. T.,
Mirza, U. A.,
Chait, B. T.,
Campbell, B. S.,
and Quilliam, L. A.
(1996)
Nature
381,
380-381[CrossRef][Medline]
[Order article via Infotrieve]
57.
Xanthoudakis, S.,
Miao, G.,
Wang, F.,
Pan, Y. C.,
and Curran, T.
(1992)
EMBO J.
11,
3323-3335[Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Sela, N. Yaffe, and J. Shlomai Enzymatic Mechanism Controls Redox-mediated Protein-DNA Interactions at the Replication Origin of Kinetoplast DNA Minicircles J. Biol. Chem., November 14, 2008; 283(46): 32034 - 32044. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Beck, S.-J. Park, Y.-J. Lee, Y. Roman, R. A. Hromas, and S.-H. Lee Human Pso4 Is a Metnase (SETMAR)-binding Partner That Regulates Metnase Function in DNA Repair J. Biol. Chem., April 4, 2008; 283(14): 9023 - 9030. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lin, J. B. Robbins, E. K. D. Nyannor, Y.-H. Chen, and I. K. O. Cann A CCCH Zinc Finger Conserved in a Replication Protein A Homolog Found in Diverse Euryarchaeotes J. Bacteriol., December 1, 2005; 187(23): 7881 - 7889. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Park, S. L. M. Ciccone, B. D. Beck, B. Hwang, B. Freie, D. W. Clapp, and S.-H. Lee Oxidative Stress/Damage Induces Multimerization and Interaction of Fanconi Anemia Proteins J. Biol. Chem., July 16, 2004; 279(29): 30053 - 30059. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Onn, N. Milman-Shtepel, and J. Shlomai Redox Potential Regulates Binding of Universal Minicircle Sequence Binding Protein at the Kinetoplast DNA Replication Origin Eukaryot. Cell, April 1, 2004; 3(2): 277 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kurek, Y. Kawagoe, D. Jacob-Wilk, M. Doblin, and D. Delmer Dimerization of cotton fiber cellulose synthase catalytic subunits occurs via oxidation of the zinc-binding domains PNAS, August 20, 2002; 99(17): 11109 - 11114. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cuesta, X. Geng, A. Asenjo, and N. Villanueva Structural Phosphoprotein M2-1 of the Human Respiratory Syncytial Virus Is an RNA Binding Protein J. Virol., November 1, 2000; 74(21): 9858 - 9867. [Abstract] [Full Text] |
||||
![]() |
S. Homburg, L. Visochek, N. Moran, F. Dantzer, E. Priel, E. Asculai, D. Schwartz, V. Rotter, N. Dekel, and M. Cohen-Armon A Fast Signal-induced Activation of Poly(ADP-ribose) Polymerase: A Novel Downstream Target of Phospholipase C J. Cell Biol., July 24, 2000; 150(2): 293 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bochkareva, S. Korolev, and A. Bochkarev The Role for Zinc in Replication Protein A J. Biol. Chem., August 25, 2000; 275(35): 27332 - 27338. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Knapp and E. Klann Superoxide-induced Stimulation of Protein Kinase C via Thiol Modification and Modulation of Zinc Content J. Biol. Chem., July 28, 2000; 275(31): 24136 - 24145. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Jakob, M. Eser, and J. C. A. Bardwell Redox Switch of Hsp33 Has a Novel Zinc-binding Motif J. Biol. Chem., December 1, 2000; 275(49): 38302 - 38310. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||